Cargando…

Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment

Licochalcone A (Lico-A) is a flavonoid compound derived from the root of the Glycyrrhiza species, a plant commonly used in traditional Chinese medicine. While the Glycyrrhiza species has shown promise in treating various diseases such as cancer, obesity, and skin diseases due to its active compounds...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olloquequi, Jordi, Ettcheto, Miren, Cano, Amanda, Fortuna, Ana, Bicker, Joana, Sánchez-Lopez, Elena, Paz, Cristian, Ureña, Jesús, Verdaguer, Ester, Auladell, Carme, Camins, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531537/ https://www.ncbi.nlm.nih.gov/pubmed/37762479 http://dx.doi.org/10.3390/ijms241814177

Ejemplares similares

A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2023)

Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
por: Ettcheto, Miren, et al.
Publicado: (2021)

Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2022)

Current Research Therapeutic Strategies for Alzheimer's Disease Treatment
por: Folch, Jaume, et al.
Publicado: (2016)

JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function
por: Busquets, Oriol, et al.
Publicado: (2022)

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
por: Folch, Jaume, et al.
Publicado: (2018)

Dual Mkk4 and Mkk7 Gene Deletion in Adult Mouse Causes an Impairment of Hippocampal Immature Granule Cells
por: Castro-Torres, Rubén Darío, et al.
Publicado: (2021)

The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
por: Folch, Jaume, et al.
Publicado: (2019)

Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
por: Folch, Jaume, et al.
Publicado: (2018)

Involvement of JNK1 in Neuronal Polarization During Brain Development
por: Castro-Torres, Rubén Darío, et al.
Publicado: (2020)

The Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies
por: Rayatpour, Atefeh, et al.
Publicado: (2021)

Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment
por: Busquets, Oriol, et al.
Publicado: (2019)

Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
por: Poor, Saghar Rabiei, et al.
Publicado: (2021)

Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation
por: Galindo, Ruth, et al.
Publicado: (2022)

Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
por: Ettcheto, Miren, et al.
Publicado: (2020)

Experimental Models for Aging and their Potential for Novel Drug Discovery
por: Folch, Jaume, et al.
Publicado: (2018)

Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
por: Ettcheto, Miren, et al.
Publicado: (2017)

Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
por: Ettcheto, Miren, et al.
Publicado: (2019)

Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease
por: Rabieipoor, Saghar, et al.
Publicado: (2023)

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
por: Cano, Amanda, et al.
Publicado: (2019)

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
por: Sánchez-López, Elena, et al.
Publicado: (2018)

Lipid Nanoparticles for the Posterior Eye Segment
por: Bonilla, Lorena, et al.
Publicado: (2021)

Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges
por: Bonilla, Lorena, et al.
Publicado: (2021)

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
por: Cano, Amanda, et al.
Publicado: (2021)

Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges
por: Cano, Amanda, et al.
Publicado: (2023)

Current Applications of Nanoemulsions in Cancer Therapeutics
por: Sánchez-López, Elena, et al.
Publicado: (2019)

State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks
por: García-Torra, Victor, et al.
Publicado: (2021)

Caffeic Acid Phenethyl Ester (CAPE): Biosynthesis, Derivatives and Formulations with Neuroprotective Activities
por: Pérez, Rebeca, et al.
Publicado: (2023)

Microbial Transformation of Licochalcones
por: Xiao, Yina, et al.
Publicado: (2019)

Multitarget therapeutic strategies for Alzheimer’s disease
por: Ibrahim, Mostafa M., et al.
Publicado: (2019)

Selecting Multitarget Peptides for Alzheimer’s Disease
por: Kasus-Jacobi, Anne, et al.
Publicado: (2022)

Extracellular vesicles, the emerging mirrors of brain physiopathology
por: Cano, Amanda, et al.
Publicado: (2023)

State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections
por: Cano, Amanda, et al.
Publicado: (2020)

Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
por: Souto, Eliana B., et al.
Publicado: (2019)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
por: Marotta, Giambattista, et al.
Publicado: (2020)

Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study
por: Sánchez-López, Elena, et al.
Publicado: (2020)

Antioxidant Mechanisms of Echinatin and Licochalcone A
por: Liang, Minshi, et al.
Publicado: (2018)

Microbial Conjugation Studies of Licochalcones and Xanthohumol
por: Han, Fubo, et al.
Publicado: (2021)

Anticancer effects of licochalcones: A review of the mechanisms
por: Deng, Nan, et al.
Publicado: (2023)

Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
por: Sánchez-López, Elena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_94a70mr1l25t1f4ltvof36ts9c